AQR reports 5.09% stake in Exelixis
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC report beneficial ownership of 13,658,388 shares of Exelixis, Inc. common stock, representing 5.09% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC report beneficial ownership of 13,658,388 shares of Exelixis, Inc. common stock, representing 5.09% of the class. They hold shared power to vote and dispose of these shares, with no sole voting or dispositive power.
The firms state the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Exelixis.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Exelixis (EXEL) does AQR report owning in this Schedule 13G?
AQR reports beneficial ownership of 5.09% of Exelixis common stock. This stake corresponds to 13,658,388 shares, giving AQR and its holding company a significant reporting-level position without crossing into control-focused ownership.
What is the nature of AQR’s investment in Exelixis (EXEL) according to the filing?
AQR certifies the Exelixis shares were acquired and are held in the ordinary course of business. The filing states they were not acquired to change or influence control of Exelixis, aligning with a passive investment stance.
Which entities are the reporting persons for this Exelixis (EXEL) Schedule 13G?
The reporting persons are AQR Capital Management, LLC and AQR Capital Management Holdings, LLC. The filing notes that AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC, and the statement is filed on behalf of both.
When did AQR’s reportable event in Exelixis (EXEL) occur for this Schedule 13G?
The date of the event requiring this Schedule 13G filing is December 31, 2025. That date marks when AQR’s beneficial ownership position in Exelixis reached a level that triggered the reporting obligation.
AI-generated analysis. How Rhea-AI works. Not financial advice.